Sandra Rose is Head of Market Access & Public Affairs CEE / Rare Disease and a Member of the Executive Committee CEE at Chiesi Group. A Market Access and Health Economics expert with over 16 years of experience, she has a strong track record of delivering timely and broad patient access to treatments. Sandra has held roles across leading pharmaceutical companies, working in diverse therapeutic areas in France, Central and Eastern Europe, Russia, and Israel. She is known for her organized, creative, and people-focused approach, combining strategic insight with a passion for impact and results.

Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries, and counts more than 6,500 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.